Compare Equitable Holdings Inc. Common Stock (EQH) vs Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equitable Holdings Inc. Common Stock vs Haleon plc American Depositary Shares (Each representing two Ordinary Shares) — how do they compare? Equitable Holdings Inc. Common Stock trades at $52.77 (market cap $14.42B), while Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.92 (market cap $42.21B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is far larger — about 2.9× Equitable Holdings Inc. Common Stock's market cap, and Equitable Holdings Inc. Common Stock pays the higher dividend (2.16%). Which is the better fit depends on your goals — on Pluang, investors hold Equitable Holdings Inc. Common Stock for 0 Days and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) for 3 Days on average.
| EQH | HLN | |
|---|---|---|
Market Cap | $14.42B | $42.21B |
Volume | 2,107,298 | 13,841,864 |
Sector | Financials | Health |
52-Week High | $54.50 | $11.27 |
52-Week Low | $35.34 | $8.70 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $5.48B | $52.02B |
Dividend Yield | 2.16% | 2.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Equitable Holdings (EQH) trades at $53.12, down 0.75% on the day, with strong analyst support (95% buy ratings) and a $64.71 consensus price target suggesting 22% upside. Recent quarterly earnings have consistently beaten expectations, though the company reported a net loss of $1.38B for 2025. The planned merger with Corebridge and expansion into fee-based businesses are key growth drivers, while high debt-to-asset ratio of 2.07 presents financial risk.
EQH shows mixed fundamentals with positive earnings momentum but negative profitability metrics. The stock offers significant upside potential based on analyst targets, supported by strategic initiatives and dividend appeal. Key risks include execution of the Corebridge merger, persistent net losses, and high leverage. Investors should weigh strong analyst conviction against fundamental weaknesses.
Haleon (HLN) trades at $9.44, down 0.63% today, with strong technical momentum showing a bullish moving average signal. The company demonstrates robust fundamentals with $11.03B revenue, 14.55% net margin, and consistent earnings beats in recent quarters. Recent business developments include successful shelf space negotiations with major retailers and growth from weight-loss drug side-effect products.
The outlook remains positive with 75% analyst buy ratings and improving cash flow projections for 2026. Key opportunities include market share gains and margin expansion, while risks involve competitive pressures and potential margin compression. The stock presents a balanced risk-reward profile for investors seeking exposure to consumer healthcare.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Equitable Holdings Inc. Common Stock
Equitable Holdings, Inc. is a financial services holding company operating through Equitable, AllianceBernstein, and Equitable Advisors. It provides retirement and protection products, asset and wealth management services, and financial planning through a network of registered financial professionals.
Read more on EQH →About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.
Read more on HLN →
